You are here

Clinical Trials: Cord Blood

Conditions:   High Risk Hematological Malignancy;   Cord Blood Transplant
Intervention:   Biological: ECT-001-CB (UM171-Expanded Cord Blood Transplant)
Sponsors:   ExCellThera inc.;   Fred Hutchinson Cancer Research Center
Recruiting
Condition:   Cerebral Palsy
Interventions:   Biological: Low HLA group CBU infusion;   Biological: High HLA group CBU infusion;   Other: Standard therapy
Sponsors:   State-Financed Health Facility "Samara Regional Medical Center Dinasty";   INBIO, LLC
Recruiting
Conditions:   Acute Erythroid Leukemia;   Acute Lymphoblastic Leukemia;   Acute Megakaryoblastic Leukemia;   Acute Myeloid Leukemia;   Blasts Under 10 Percent of Bone Marrow Nucleated Cells;   Blasts Under 5 Percent of Bone Marrow Nucleated Cells;   Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Hematopoietic and Lymphoid Cell Neoplasm;   Human Immunodeficiency Virus Positive;   Myelodysplastic Syndrome;   Myelodysplastic Syndrome With Excess Blasts;   Non-Hodgkin Lymphoma;   Refractory Anemia
Interventions:   Drug: Fludarabine;   Drug: Fludarabine Phosphate;   Drug: Cyclophosphamide;   Drug: Thiotepa;   Radiation: Total-Body Irradiation;   Procedure: Umbilical Cord Blood Transplantation;   Other: Cellular Therapy
Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI);   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
Condition:   Pulmonary Hypertension
Interventions:   Biological: adipose derived mesenchymal stem cells;   Drug: Conventional drug therapy(expectorant,bronchodilator)
Sponsor:   Liaocheng People's Hospital
Recruiting
Condition:   Irreversible Pulpitis
Interventions:   Other: Cord blood stem cells;   Other: Saline solution
Sponsor:   University of California, San Francisco
Not yet recruiting
Condition:   Knee Osteoarthritis
Interventions:   Biological: SMUP-IA-01(low-dose);   Biological: SMUP-IA-01(mid-dose);   Biological: SMUP-IA-01(high-dose)
Sponsor:   Medipost Co Ltd.
Not yet recruiting
Condition:   Viral Infection
Intervention:   Biological: HLA-matched VSTs
Sponsors:   Baylor College of Medicine;   The Methodist Hospital System;   Texas Children's Hospital
Not yet recruiting
Conditions:   Stroke;   Umbilical Cord Blood;   Erythropoietin;   Safety;   Treatment Outcome
Interventions:   Drug: Umbilical cord blood infusion;   Drug: Erythropoietin injection;   Drug: Placebo umbilical cord blood infusion;   Drug: Placebo erythropoietin injection;   Procedure: Active rehabilitation
Sponsors:   Bundang CHA Hospital;   Korea Evaluation Institute of Industrial Technology
Recruiting
Conditions:   Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis
Intervention:   Combination Product: Stem Cell Educator therapy combined with minoxidil
Sponsors:   Tianhe Stem Cell Biotechnologies Inc.;   Yale University;   Hackensack Meridian Health
Not yet recruiting
Condition:   Type 1 Diabetes
Intervention:   Combination Product: Stem Cell Educator therapy
Sponsors:   Tianhe Stem Cell Biotechnologies Inc.;   Hackensack Meridian Health
Not yet recruiting

Pages